Through the first nine months of 2025, the company generated $422 million in revenue -- representing an increase of 39% year ...

Shares of Abbott Laboratories plunged 10.04% to $108.61 Thursday, on what proved to be an all-around great trading session ...

Rocket Lab (RKLB)’s stock surged 45%, driven not only by a robust 10% increase in revenue but also by a significant 36% ...

Abbott Labs stock drops on sales miss and weak guidance for 2026, analyst cuts price target but maintains rating.

Abbott shares sank 8% as Q4 revenue of $11.5B missed the $11.8B target, with nutrition sales dropping 8.9% on price ...

Rocket Lab completes its first 2026 launch, deploying two satellites for Open Cosmos. Electron rocket proves reliable and ...

Abbott Laboratories reported Q4 2025 sales of $11.46 billion, an increase of 4.4% from the previous year but falling short of analyst projections by approximately 3%. The adjusted EPS was $1.50, ...

Rocket Lab looks overvalued despite Neutron/defense catalysts. Click here for more on the RKLB stock prospects.

Rocket Lab stock has continued to skyrocket in 2026 and is currently up 38% year to date. Meanwhile, the S&P 500 is up 1.4%, ...

As of Friday, January 09, Rocket Lab Corporation’s RKLB share price has surged by 5.63%, which has investors questioning if ...

Rocket Lab (NASDAQ: RKLB) closed out 2025's trading with another month of huge gains. The company's share price surged 65.5% ...

Rocket Lab USA (NASDAQ:RKLB) shares jumped about 6% on Friday after Morgan Stanley upgraded the stock from Equalweight to ...